Does plasmin have anticoagulant activity?
Open Access
- 1 March 2010
- journal article
- Published by Taylor & Francis Ltd in Vascular Health and Risk Management
- Vol. 6, 199-205
- https://doi.org/10.2147/VHRM.S9358
Abstract
Does plasmin have anticoagulant activity? Jane Hoover-PlowJoseph J Jacobs Center for Thrombosis and Vascular Biology, Departments of Cardiovascular Medicine and Molecular Cardiology, Lerner Research Institute Cleveland Clinic, Ohio, USA The coagulation and fibrinolytic pathways regulate hemostasis and thrombosis, and an imbalance in these pathways may result in pathologic hemophilia or thrombosis. The plasminogen system is the primary proteolytic pathway for fibrinolysis, but also has important proteolytic functions in cell migration, extracellular matrix degradation, metalloproteinase activation, and hormone processing. Several studies have demonstrated plasmin cleavage and inactivation of several coagulation factors, suggesting plasmin may be not only be the primary fibrinolytic enzyme, but may have anticoagulant properties as well. The objective of this review is to examine both in vitro and in vivo evidence for plasmin inactivation of coagulation, and to consider whether plasmin may act as a physiological regulator of coagulation. While several studies have demonstrated strong evidence for plasmin cleavage and inactivation of coagulation factors FV, FVIII, FIX, and FX in vitro, in vivo evidence is lacking for a physiologic role for plasmin as an anticoagulant. However, inactivation of coagulation factors by plasmin may be useful as a localized anticoagulant therapy or as a combined thrombolytic and anticoagulant therapy.Keywords: thrombosis, anticoagulant, cardiovascular disease, plasminogen’s protease, bloodKeywords
This publication has 64 references indexed in Scilit:
- Intravitreal Plasmin Without Associated Vitrectomy as a Treatment for Refractory Diabetic Macular EdemaJournal of Ocular Pharmacology and Therapeutics, 2009
- Plasmin-mediated Proteolysis Is Required for Hepatocyte Growth Factor Activation during Liver RepairPublished by Elsevier BV ,2009
- Inflammatory macrophage migration requires MMP-9 activation by plasminogen in miceJCI Insight, 2008
- Sepsis-Induced Coagulation in the Baboon Lung Is Associated with Decreased Tissue Factor Pathway InhibitorThe American Journal of Pathology, 2007
- The effects of intrinsic pathway protease deficiencies on plasminogen-deficient miceBlood, 2005
- Mechanisms of Interactions of Factor X and Factor Xa with the Acidic Region in the Factor VIII A1 DomainPublished by Elsevier BV ,2004
- Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial FunctionStroke, 2003
- The Role of the Membrane in the Inactivation of Factor Va by PlasminPublished by Elsevier BV ,2001
- Mechanism of Factor Va Inactivation by Plasmin: LOSS OF A2 AND A3 DOMAINS FROM A Ca2+-DEPENDENT COMPLEX OF FRAGMENTS BOUND TO PHOSPHOLIPIDPublished by Elsevier BV ,2001
- A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.Stroke, 1994